APA (7th ed.) Citation

Komatsu, S., Nomiyama, T., Numata, T., Kawanami, T., Hamaguchi, Y., Iwaya, C., . . . Kawanami, D. (2020). SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation. ENDOCRINE JOURNAL, 67(1), 99-106. https://doi.org/10.1507/endocrj.EJ19-0428

Chicago Style (17th ed.) Citation

Komatsu, Shiho, et al. "SGLT2 Inhibitor Ipragliflozin Attenuates Breast Cancer Cell Proliferation." ENDOCRINE JOURNAL 67, no. 1 (2020): 99-106. https://doi.org/10.1507/endocrj.EJ19-0428.

MLA (9th ed.) Citation

Komatsu, Shiho, et al. "SGLT2 Inhibitor Ipragliflozin Attenuates Breast Cancer Cell Proliferation." ENDOCRINE JOURNAL, vol. 67, no. 1, 2020, pp. 99-106, https://doi.org/10.1507/endocrj.EJ19-0428.